Return to search

A2 Biotherapeutics takes in $57 mln Series A

A2 Biotherapeutics, a developer of cell therapies for cancer patients, has raised $57 million in Series A funding. The investors included The Column Group, Vida Ventures, Samsara BioCapital and Nextech Invest.

Source: Press Release